Skip to content
Entourage
Case studyMedical Devices

Design Transfer of Combination Products from Development to Production

  • 25% faster regulatory approval
  • 15% reduction in transfer costs

A medical device company developing combination products

A medical device company with combination products needed to make the design transfer from development to production more efficient while overcoming regulatory hurdles under the EU MDR and the FDA.

The challenge

The situation

Regulatory uncertainties under the EU MDR led to compliance delays, while the complexity of the FDA requirements under 21 CFR Part 4 created additional coordination needs. Limited internal resources and a lack of specialist expertise compounded the situation, and operational gaps in the transition from development to production delayed market entry through lengthy approval processes.

Our approach

How Entourage approached it

01

Gap analysis to assess the design transfer and the compliance gaps

02

Regulatory support on the EU MDR and FDA 21 CFR Part 4

03

Process optimization for the transition from development to production

04

Cross-functional expertise to close internal resource and knowledge gaps

05

Implementation of modern processes for a more efficient production workflow

The outcome

What changed

The market launch was successful and faster, with reduced costs, a more efficient production process, and greater competitiveness.

  • 25% faster regulatory approval

    Regulatory approval was accelerated by 25 percent.

  • 15% reduction in transfer costs

    The cost of the design transfer decreased by 15 percent.

  • Accelerated market entry

    Market entry was achieved faster than previously possible.

Your next step

What this topic involves and how we work is set out on the topic page.

Production Transfer & Scale-Up →

To start, the On-site Quick Check brings us to your site for one to three days to check the current state.

About the On-site Quick Check →

Regulations & standards considered

  • EU MDR (Regulation (EU) 2017/745)
  • FDA 21 CFR Part 4 (combination products)

Image notice: The images on this page were generated using artificial intelligence. They do not depict real people, places, or events.

Your project

A comparable project?

Briefly outline your situation. We'll respond with an initial assessment, usually within one business day.

Prefer direct? +49 89 4161170-0
contact@theentourage.de

  • Reply usually within one working day
  • 3 locations: DE · CH · IT · projects in the US too
  • 100% life sciences